ABVX logo

ABIVAX Société Anonyme (ABVX) Cash From Financing

Annual CFF:

$38.84M-$329.36M(-89.45%)
December 31, 2024

Summary

  • As of today, ABVX annual cash from financing is $38.84 million, with the most recent change of -$329.36 million (-89.45%) on December 31, 2024.
  • During the last 3 years, ABVX annual cash from financing has fallen by -$53.96 million (-58.15%).
  • ABVX annual cash from financing is now -89.45% below its all-time high of $368.19 million, reached on December 31, 2023.

Performance

1-Year Change

-89.45%

3-Year Change

-58.15%

5-Year Change

+40.98%

15-Year Change

+204.02%

ABVX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

71.92%
ABVX annual cash from financing is higher than 71.92% of companies in Healthcare sector

Range

All-Time High

$368.19M
ABVX annual cash from financing is currently -89.45% below its historical high of $368.19 million

3-Year Low

$38.07M
ABVX annual cash from financing is currently +2.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ABVX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ABVX next annual earnings announcement has not yet been scheduled

OtherABVXcash flow metrics

Annual CFI

$8.20M
ABVX annual cash from investing is $8.20 million

Annual CFO

-$166.14M
ABVX annual cash from operations is -$166.14 million

Annual FCF

-$166.83M
ABVX annual free cash flow is -$166.83 million

Annual CAPEX

$695.50K
ABVX annual capital expenditures is $695.50 thousand

Quarterly CFF:

$681.20M+$688.87M(+8984.93%)
September 1, 2025

Summary

  • As of today, ABVX quarterly cash from financing is $681.20 million, with the most recent change of +$688.87 million (+8984.93%) on September 1, 2025.
  • Over the past year, ABVX quarterly cash from financing has increased by +$687.38 million (+11122.45%).
  • ABVX quarterly cash from financing is now at all-time high.

Performance

3-Month Change

+8984.93%

1-Year Change

+11122.45%

3-Year Change

-

5-Year Change

-

ABVX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

99.37%
ABVX quarterly cash from financing is higher than 99.37% of companies in Healthcare sector

Range

All-Time High

$681.20M
ABVX quarterly cash from financing is currently at an all-time high

3-Year Low

-$7.67M
ABVX quarterly cash from financing is currently +8984.93% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2025
ABVX previous earnings announcement was published on Sep 1, 2025

Next Quarterly Earnings Report Date

N/A
ABVX next earnings announcement has not yet been scheduled

OtherABVXcash flow metrics

Quarterly CFI

-$194.70K
ABVX quarterly cash from investing is -$194.70 thousand

Quarterly CFO

-$80.91M
ABVX quarterly cash from operations is -$80.91 million

Quarterly FCF

-
ABVX quarterly free cash flow value is unknown

Quarterly CAPEX

-
ABVX quarterly capital expenditures value is unknown

TTM CFF:

$667.35M+$681.20M(+4919.47%)
September 1, 2025

Summary

  • As of today, ABVX TTM cash from financing is $667.35 million, with the most recent change of +$681.20 million (+4919.47%) on September 1, 2025.
  • Over the past year, ABVX TTM cash from financing has increased by +$673.53 million (+10898.39%).
  • ABVX TTM cash from financing is now at all-time high.

Performance

3-Month Change

+4919.47%

1-Year Change

+10898.39%

3-Year Change

-

5-Year Change

-

ABVX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

98.92%
ABVX TTM cash from financing is higher than 98.92% of companies in Healthcare sector

Range

All-Time High

$667.35M
ABVX TTM cash from financing is currently at an all-time high

3-Year Low

-$13.85M
ABVX TTM cash from financing is currently +4919.47% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2025
ABVX previous earnings announcement was published on Sep 1, 2025

Next Quarterly Earnings Report Date

N/A
ABVX next earnings announcement has not yet been scheduled

OtherABVXcash flow metrics

TTM CFI

-$95.80K
ABVX TTM cash from investing is -$95.80 thousand

TTM CFO

-$156.27M
ABVX TTM cash from operations is -$156.27 million

TTM FCF

-
ABVX TTM free cash flow value is unknown

TTM CAPEX

-
ABVX TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ABVX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-89.5%+10000.0%+10000.0%
3Y3 Years-58.1%--
5Y5 Years+41.0%--

ABVX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-89.5%+2.0%at high+8984.9%at high+4919.5%
5Y5-Year-89.5%+2.0%at high+8984.9%at high+4919.5%
All-TimeAll-Time-89.5%+8115.7%at high+8984.9%at high+4919.5%

ABVX Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$681.20M(+8984.9%)
$667.35M(+4919.5%)
Jun 2025
-
-$7.67M(-24.1%)
-$13.85M(-124.1%)
Mar 2025
-
-$6.18M(-126.8%)
-$6.18M(-126.8%)
Dec 2024
$38.84M(-89.5%)
-
-
Mar 2024
-
$23.03M
$23.03M
Dec 2023
$368.19M(+867.1%)
-
-
Dec 2022
$38.07M(-59.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
$92.80M(+63.0%)
-
-
Dec 2020
$56.92M(+106.6%)
-
-
Dec 2019
$27.55M(+115.6%)
-
-
Dec 2018
$12.77M(+335.8%)
-
-
Dec 2017
$2.93M(+705.1%)
-
-
Dec 2016
-$484.50K(-100.8%)
-
-
Dec 2015
$57.80M(+631.6%)
-
-
Dec 2014
$7.90M
-
-

FAQ

  • What is ABIVAX Société Anonyme annual cash from financing?
  • What is the all-time high annual cash from financing for ABIVAX Société Anonyme?
  • What is ABIVAX Société Anonyme annual cash from financing year-on-year change?
  • What is ABIVAX Société Anonyme quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for ABIVAX Société Anonyme?
  • What is ABIVAX Société Anonyme quarterly cash from financing year-on-year change?
  • What is ABIVAX Société Anonyme TTM cash from financing?
  • What is the all-time high TTM cash from financing for ABIVAX Société Anonyme?
  • What is ABIVAX Société Anonyme TTM cash from financing year-on-year change?

What is ABIVAX Société Anonyme annual cash from financing?

The current annual cash from financing of ABVX is $38.84M

What is the all-time high annual cash from financing for ABIVAX Société Anonyme?

ABIVAX Société Anonyme all-time high annual cash from financing is $368.19M

What is ABIVAX Société Anonyme annual cash from financing year-on-year change?

Over the past year, ABVX annual cash from financing has changed by -$329.36M (-89.45%)

What is ABIVAX Société Anonyme quarterly cash from financing?

The current quarterly cash from financing of ABVX is $681.20M

What is the all-time high quarterly cash from financing for ABIVAX Société Anonyme?

ABIVAX Société Anonyme all-time high quarterly cash from financing is $681.20M

What is ABIVAX Société Anonyme quarterly cash from financing year-on-year change?

Over the past year, ABVX quarterly cash from financing has changed by +$687.38M (+11122.45%)

What is ABIVAX Société Anonyme TTM cash from financing?

The current TTM cash from financing of ABVX is $667.35M

What is the all-time high TTM cash from financing for ABIVAX Société Anonyme?

ABIVAX Société Anonyme all-time high TTM cash from financing is $667.35M

What is ABIVAX Société Anonyme TTM cash from financing year-on-year change?

Over the past year, ABVX TTM cash from financing has changed by +$673.53M (+10898.39%)
On this page